TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Stay on the Sidelines

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could experience wonderful growth, but for now, it's best to avoid it because it is…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Buy Now, Say Analysts

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been hit hard by recent scandals and poses significant speculative risk to investors. At…

    Read more »

    The Motley Fool
    Energy Stocks

    Valeant Pharmaceuticals Intl Inc. vs. Baytex Energy Corp.: Which Is a Better Bet?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Baytex Energy Corp. (TSX:BTE)(NYSE:BTE) are two of Canada's fallen stars. Is one about to…

    Read more »

    The Motley Fool
    Investing

    Saving Face at Valeant Pharmaceuticals Intl Inc.

    Is the fate of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) really in its own hands?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A Year in Review

    Few companies had a memorable 2016 as much as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Here's a look at how the…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Will Continue to Be a Loser in 2017

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) was a loser in 2016 and will continue to be a loser in 2017 as…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Next Stop $10?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) remains a risky bet.

    Read more »

    The Motley Fool
    Investing

    Is Kevin O’Leary Right About Valeant Pharmaceuticals Intl Inc.?

    Many investors are quite bearish on Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), including Kevin O'Leary. Is Mr. Wonderful on to something…

    Read more »

    The Motley Fool
    Investing

    Making the Case for Valeant Pharmaceuticals Intl Inc.: Why it’s Not Worth it Yet

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) stock has been in shambles in 2016, plummeting more than 83%, but there is reason…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is This Stock Worth a Contrarian Shot for 2017?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a seriously unloved stock. Is it finally time to buy?

    Read more »

    Investing

    Will Canopy Growth Corp. Crash as Hard as Valeant Pharmaceuticals Intl Inc.?

    Canopy Growth Corp. (TSX:CGC) has been falling hard over the last week. Will this company face the same fate as…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Has This Stock Finally Hit Bottom?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is getting a nice post-election bounce. Is this the time to buy?

    Read more »